Literature DB >> 6692240

Toxic shock syndrome: clinical and laboratory findings in 30 patients.

A W Chow, C K Wong, A M MacFarlane, K H Bartlett.   

Abstract

Thirty patients with toxic shock syndrome (TSS) that developed between May 1980 and March 1983 in Vancouver were studied prospectively. In the 15 cases related to menstruation the illness followed a uniform and predictable clinical course. In the 15 other cases (3 in males) the disease was not related to menstruation, and the sources of the Staphylococcus aureus infections were diverse; 67% were hospital-acquired. Profound but transient lymphocytopenia associated with marked leukocytosis was the most striking laboratory finding and one not previously emphasized in the literature. S. aureus was isolated from sites of soft-tissue infection, the vagina or the endocervix in all except one case. Two patients had bacteremia. Phage types 29 and 29 + predominated among the isolates tested. All the genital S. aureus isolates tested produced the TSS marker protein, while the bacteria from wounds, throat, nose and blood were sometimes positive. Two patients (7%) died from refractory shock and multiple organ failure. All patients with a febrile, exanthematous, multisystem illness, particularly if it is associated with menstruation or a staphylococcal infection, should be evaluated promptly and treated empirically for TSS.

Entities:  

Mesh:

Year:  1984        PMID: 6692240      PMCID: PMC1876096     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  15 in total

1.  Tri-state toxic-state syndrome study. I. Epidemiologic findings.

Authors:  M T Osterholm; J P Davis; R W Gibson; J S Mandel; L A Wintermeyer; C M Helms; J C Forfang; J Rondeau; J M Vergeront
Journal:  J Infect Dis       Date:  1982-04       Impact factor: 5.226

Review 2.  Toxic shock syndrome in Canada.

Authors:  A J Clayton; J E Peacocke; P E Ewan
Journal:  Can Med Assoc J       Date:  1982-04-01       Impact factor: 8.262

3.  Clinical manifestations of toxic shock syndrome.

Authors:  P J Chesney; J P Davis; W K Purdy; P J Wand; R W Chesney
Journal:  JAMA       Date:  1981-08-14       Impact factor: 56.272

4.  Tri-state toxic-shock syndrome study. II. Clinical and laboratory findings.

Authors:  J P Davis; M T Osterholm; C M Helms; J M Vergeront; L A Wintermeyer; J C Forfang; L A Judy; J Rondeau; W L Schell
Journal:  J Infect Dis       Date:  1982-04       Impact factor: 5.226

5.  Toxic shock syndrome, a newly recognized disease entity. Report of 11 cases.

Authors:  U G McKenna; J A Meadows; N S Brewer; W R Wilson; J Perrault
Journal:  Mayo Clin Proc       Date:  1980-11       Impact factor: 7.616

6.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

7.  Nonmenstrual toxic shock syndrome: a review of 130 cases.

Authors:  A L Reingold; N T Hargrett; B B Dan; K N Shands; B Y Strickland; C V Broome
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

8.  Persistent neuropsychological sequelae of toxic shock syndrome.

Authors:  K A Rosene; M K Copass; L S Kastner; C M Nolan; D A Eschenbach
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

9.  Toxic shock syndrome associated with surgical wound infections.

Authors:  P Bartlett; A L Reingold; D R Graham; B B Dan; D S Selinger; G W Tank; K A Wichterman
Journal:  JAMA       Date:  1982-03-12       Impact factor: 56.272

10.  Toxic shock syndrome: clinical and laboratory features in 15 patients.

Authors:  R W Tofte; D N Williams
Journal:  Ann Intern Med       Date:  1981-02       Impact factor: 25.391

View more
  2 in total

Review 1.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

2.  Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay.

Authors:  P M Rosten; K H Bartlett; A W Chow
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.